BioSpace News Archive

Business

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

Fate Therapeutics, Inc. reported business highlights and financial results for the third quarter ended September 30, 2023.

November 8, 2023
·
15 min read
Business

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.

November 8, 2023
·
13 min read
Drug Development

Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

HCW Biologics Inc.announced results from a preliminary human data readout from an ongoing Phase 1 clinical trial sponsored by the University of Minnesota to evaluate HCW9218, the lead drug candidate of HCW Biologics, in patients with solid tumors who failed at least two prior lines of therapy.

November 8, 2023
·
8 min read
BioForest

Icosavax to Participate in the 2023 Jefferies London Healthcare Conference

Icosavax, Inc. announced that the company will participate in and host one-on-one meetings at the Jefferies London Healthcare Conference, taking place from November 14-16, 2023 in London, UK.

November 8, 2023
·
1 min read
Business

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

Avid Bioservices, Inc. announced a new partnership with the California Institute for Regenerative Medicine Industry Resource Partner Program.

November 8, 2023
·
4 min read
Business

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer.

November 8, 2023
·
5 min read
Biotech Bay

Pliant Therapeutics to Participate in Upcoming November 2023 Investor Conferences

Pliant Therapeutics, Inc., a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, announced participation in the following November investor conferences.

November 8, 2023
·
2 min read
BioMidwest

Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption

Aclarion, Inc. announced that they have successfully achieved their goal of enrolling ten leading spine surgery KOLs to assist the company in driving Nociscan to standard of care for identifying discogenic low back pain.

November 8, 2023
·
5 min read
Genetown

New Study Confirms Power of Real-World Data in Proactive Signal Detection, Improving Patient Safety

ArisGlobal, creator of the LifeSphere® technology platform and a market leader in global patient treatment solutions, has announced striking new study results confirming the power of Proactive Safety Signal Detection in improving patient safety.

November 8, 2023
·
4 min read
BioMidwest

Sling Therapeutics to Participate in Upcoming Investor Conferences

Sling Therapeutics, Inc. will be participating in three upcoming investor conferences in November 2023.

November 8, 2023
·
1 min read